Document Detail


Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans.
MedLine Citation:
PMID:  11185664     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objective of this study is to evaluate whether unbound clearance of a drug can be predicted more accurately than total clearance using the allometric approach and if there is any real advantage of predicting unbound clearance over total clearance. The total and unbound clearance of 20 randomly selected drugs were scaled up from the animal data (at least three animal species) obtained from the literature. Three methods were used to generate plots to scale up the clearance values: (1) total or unbound clearance versus body weight (simple allometric equation), (2) the product of total or unbound clearance and maximum life span potential (MLP) versus body weight, and (3) the product of total or unbound clearance and brain weight versus body weight. The results of this study indicate that there will be instances when unbound clearance can be predicted better than total clearance or vice versa. In conclusion, unbound clearance cannot be predicted any better than total clearance.
Authors:
I Mahmood
Related Documents :
3180634 - The influence of nonsteroidal anti-inflammatory drugs and probenecid on the renal respo...
6726634 - Excretion, distribution, and metabolism of primaquine in rats.
3719894 - The clinical pharmacology of mitozantrone.
24613634 - Contribution of inertial cavitation in the enhancement of in vitro transscleral drug d...
18057794 - preparation and release profile of colon-targeting drug delivered as novel one-step dry...
8853234 - Validity of self-reported drug use in high risk populations: a meta-analytical review.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  40     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2000-12-11     Completed Date:  2000-12-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1439-46     Citation Subset:  IM    
Affiliation:
Division of Pharmaceutical Evaluation I, Office of Clinical Pharmacology and Biopharmaceutics, Food and Drug Administration, Rockville, Maryland 20852, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Design*
Humans
Metabolic Clearance Rate
Models, Animal
Pharmacokinetics*
Protein Binding
Species Specificity

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics/pharmacodynamics in drug development: an industrial perspective.
Next Document:  Iron supplementation in preterm infants: a study comparing the effect and tolerance of a Fe2+ and a ...